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Recent findings challenge the concept that microglia solely function in disease states in the central
nervous system (CNS). Rather than simply reacting to CNS injury, infection, or pathology, emerging
lines of evidence indicate that microglia sculpt the structure of the CNS, refine neuronal circuitry
and network connectivity, and contribute to plasticity. These physiological functions of microglia
in the normal CNS begin during development and persist into maturity. Here, we develop a concep-
tual framework for functions of microglia beyond neuroinflammation and discuss the rich repertoire
of signaling and communication motifs in microglia that are critical both in pathology and for the
normal physiology of the CNS.Introduction
The pervasive view of microglia is that their singular function is
as inflammatory cellular mediators in diseases of the CNS. This
view was seemingly cemented with the discovery that, within
the lattice-like pattern of adjacent, nonoverlapping territories,
microglia respond within minutes to even highly restricted areas
of damage as small as a single neuronal process (Davalos
et al., 2005; Nimmerjahn et al., 2005). Moreover, microglia
adopt stimulus-dependent phenotypes in response to more
widespread injury, infection, or disease. The response reper-
toire of microglia includes cytoskeletal rearrangements leading
to morphological changes, stereotypic transcriptional alter-
ations, and proliferation. Thus, microglia keep vigilant for dis-
ruptions to the status quo in the CNS, responding to specific
threats in highly programmed ways and calling in reinforce-
ments as needed.
But most of the time the CNS is not under imminent threat
or attack. What then are microglia doing, if anything, in the
normal, healthy CNS? With increasingly sophisticated tools, it
has been possible to gain insights into this question probing
not only the functions of microglia in injury and disease, but
also their functions under healthy conditions. The concept that
microglia may participate in healthy CNS function was blown
wide open by the discovery that microglia processes are highly
active, continuously scanning the environment (Davalos et al.,
2005; Nimmerjahn et al., 2005). Subsequent results have been
astonishing, revealing unexpected roles for microglia in normal
development, connectivity, and plasticity in the CNS. A common
theme across the physiological roles for microglia is that these
cells can be seen as instructive, unlike during or following injury,
infection, or disease, during which the microglia are viewed as
reactive (Schafer et al., 2013; Tremblay et al., 2011; Wake
et al., 2013). Thus, microglia are not restricted to respondingwhen things go wrong but are active players in shaping activity
in the healthy CNS.
More Than Just Inflammatory Cells
Microglia constitute 10% of the total cells in the adult CNS,
though there is considerable heterogeneity in microglia density
among CNS regions (Aguzzi et al., 2013; Kettenmann et al.,
2013; Tremblay et al., 2011). Microglia are often considered to
be macrophages of the CNS, but a series of recent findings in
the mouse has established that microglia are a unique cell pop-
ulation distinct from macrophages. Fate mapping has revealed
that adult microglia are derived from precursors that leave the
yolk sac on E8.5–E9.0, entering the neural tube via the primitive
bloodstream (Ginhoux et al., 2010;Greter and Merad, 2013)
(Figure 1). The erythromyeloid progenitors that give rise to
migrating cells have been identified as cells with low expression
of CD45 and high expression of c-kit (Kierdorf et al., 2013). As
the progenitor cells journey to the CNS, they gain lineage-spe-
cific gene expression and ultimately differentiate into mature
microglia. The yolk-sac-derived microglia remain throughout
life, with the population being maintained by self-renewal in
the healthy CNS with little contribution from bone-marrow
macrophages (Ajami et al., 2007). Microglia development is
independent of the transcription factor Myb and of colony-stim-
ulating factor 1 (CSF-1) (Schulz et al., 2012), both of which are
essential for bone-marrow-derived macrophages (Hashimoto
et al., 2013; Yona et al., 2013). By contrast, microglia depend
upon the CSF-1 receptor (Erblich et al., 2011) through its alter-
nate ligand IL-34 (Greter et al., 2012), which is principally pro-
duced by neurons (Wang et al., 2012). PU.1-dependent and
IRF8-dependent pathways are also critical for microglia (Kier-
dorf et al., 2013). The persistence of microglia in the CNS, but
not the initial seeding from yolk sac, depends upon TGFb-1 inCell 158, July 3, 2014 ª2014 Elsevier Inc. 15
Figure 1. Microglia Have a Distinct Lineage
and Molecular Signature
(A) The genesis and progression of yolk-sac-
derived cell lineages are illustrated. Microglial are
derived from primitive erythromyeloid progenitors
in the yolk sac (embryonic hematopoiesis, indi-
cated in yellow), distinct from the definitive
hematopoiesis (shown in green) from which the
majority of macrophages are derived.
(B) An illustration of the time course of microglial
derivation and embryonic colonization as revealed
by fate-mapping experiments. Microglia originate
from PU.1-dependent precursors in the yolk sac
that proliferate and invade the neuroectoderm-
derived developing CNS, as indicated by an in-
crease in the markers CX3CR1 and iba1 (shown as
orange ramp).
(C) The diagram illustrates the overlap in gene
expression between microglia, macrophages, and
monocytes. Two of the most widely used
‘‘markers,’’ CX3CR1 and cd11b, are common to all
three. Although there is considerable molecular
similarity between tissue-resident macrophages
and microglia, a subset of microglial-specific
genes have been identified, and the six most
prominent of these genes are shown (see Butov-
sky et al. [2014]).the CNS (Koeglsperger et al., 2013), whereas this cytokine is
not required for bone-marrow-derived macrophages (Hashi-
moto et al., 2013).
Transcriptome analysis has revealed that microglia have a
distinctive signature as compared with circulating macrophages
but are closely related to other tissue-resident macrophages
developing from primitive yolk sac (Butovsky et al., 2014; Hick-
man et al., 2013). A host of microglia-specific transcripts and
proteins, as well as microRNA, have been identified, character-
izing the gene network expressed by microglia in the adult brain
under normal conditions. Moreover, the stimulus-induced tran-
scriptional plasticity of microglia does not correspond to the
M1 or M2 plasticity observed with macrophages (Mills, 2012)
and is distinct from the resting state transcriptome, which has
been termed M0 (Koeglsperger et al., 2013). Thus, although
microglia and macrophages express a number of common pro-
teins, some of which are very well known such as CD11b (also
referred to as integrin aM, ITGAM), overall they are distinct
and readily distinguishable cell populations. Even when bone-
marrow-derived macrophages infiltrate the CNS, for example,
during experimental autoimmune encephalomyelitis (EAE), these
cells retain their transcriptional signature and do not adopt that
of endogenous microglia (Ajami et al., 2007; Koeglsperger
et al., 2013; Saederup et al., 2010). The dramatic transcriptome
differences between microglia and macrophages and other im-
mune cells highlight that microglia are not classical immune
cells. A rapidly growing body of evidence is increasingly demon-16 Cell 158, July 3, 2014 ª2014 Elsevier Inc.strating that microglia have a variety of
nonphlogistic functions in the normal,
healthy CNS. Thus, one may question
whether microglia are principally in-
flammatory cells. As inflammation has
emerged to be just one aspect of
their function, microglia are rightlyconsidered dual-functioning cells that are critical in the normal
as well as in the diseased CNS.
The Microglia ‘‘Surveillance and Rapid Response’’ State
in the Healthy CNS
In the normal adult CNS, microglia have a complex morphology
with highly ramified processes extending from a compact cell
body that continuously scan the environment transiently
contacting synapses as well extrasynaptic regions. The micro-
glial processes directly appose not only presynaptic terminals
and dendritic spines, but also perisynaptic astrocytic clefts
(Tremblay et al., 2010). Here, microglia are well positioned to
monitor neuronal firing activity and synaptic function, as they ex-
press receptors for numerous types of neurotransmitters and
mediators (Kettenmann et al., 2011; Koizumi et al., 2013). In
response to neuronal activity, microglia steer their processes to-
ward active synapses (Figure 2A), which facilitates contact with
highly active neurons. Using live imaging in the mouse, microglia
processes have been found to not only passively monitor
neuronal activity, but also actively respond (Tremblay et al.,
2010; Wake et al., 2009). In zebrafish, microglial processes
have been observed to enwrap the soma of highly active neurons
(Figure 2A) and subsequently the firing of the targeted neuron de-
creases (Li et al., 2012). Thus, microglia are not ‘‘resting’’ but are
highly active in a ‘‘surveillance and rapid response’’ state in
which they monitor and control the activity of neurons even in
the healthy CNS.
Figure 2. Microglia Control Neuronal Activ-
ity, Programmed Cell Death, and Synapse
Connectivity
(A) Microglia can respond to and, in turn, influence
neuronal activity. The low power image on the left
illustrates a microglia (red) with interspersed neu-
rons of high (orange) or low (gray) activity. The
high-power cartoon images illustrate that micro-
glial processes are highly motile in surveillance
mode (left) and are instructed and directed by local
neuronal activity to the most highly active neurons
(middle, right). Microglia interact with adjacent
neurons through neuronally released signaling
molecules, monitoring and directing their activity.
Microglial processes (red) engage with the soma
of highly active neurons (orange), after which there
is a decrease in both spontaneous and evoked
neuronal firing. The findings illustrated are from
live imaging in zebrafish larvae (see Li et al. [2012]).
(B) Microglia (red) drive programmed cell death
during development and the apoptosis and
removal of newborn neurons in the adult. Microglia
not only phagocytose the debris of dead and
damaged neurons but also instruct programmed
cell death (PCD) via complement-mediated
signaling events. A neuron destined for PCD is
illustrated (in green) in the images; non-PCD-
destined neurons are shown in gray. In the high-
power cartoon images, amicroglia process (red) is
attracted to the green neuron (left). The neuron is
subsequently engulfed and removed by the pro-
jecting phagocytic cup of local microglia (middle,
right).
(C) Microglial activity drives the pruning, elimina-
tion, and maturation of synapses. The images on
the upper-left illustrate low- and high-power views
of microglia (iba1, red) and neuronal cell bodies
(NeuN, green) in the mouse hippocampus. Below
is a schematic showing the microglia (red) in close
proximity to neuronal synaptic structures (green;
enclosed in gray box). The potential influence of
microglia on synaptic structures and two possible
fates are shown in the cartoon in the enlarged
boxed region on the right. The series of images on the right shows how superfluous exuberant synapses are pruned and eliminated by microglial activity. This
process involves activation of the classical complement cascade, with accumulation of C1q at targeted synapses leading to neuronal C3-microglial CR3 signaling
(see inset) and subsequent synaptic engulfment of both pre- and postsynaptic structures (green) by microglia (red). Conversely, the series on the left shows how
other appropriate synapses can be strengthened by a CX3CR1-dependent mechanism (see inset, top) and subsequent maturation through postsynaptic NMDAR
subunit changes and AMPAR insertion (see insets, bottom).Driving Programmed Cell Death in CNS Development
Microglia are present in the CNS beginning from midembryonic
stage and could therefore conceivably play a role in many as-
pects of the subsequent development of the CNS. However, in
animals lacking microglia, such as PU.1 (Beers et al., 2006; Kier-
dorf et al., 2013; Smith et al., 2013) or CFSR1 null mutants
(Erblich et al., 2011) or CNS-TGFb-1 nulls (Butovsky et al.,
2014), the gross architecture, regionalization, cell layering, and
axonal tracks of the CNS develop normally. Whether microglia
simply have no role in the major mapping of the CNS or whether
they are not yet prepared or actively suppressedwhen this struc-
turing develops is unknown, but it is clear that microglia are
dispensable for the broad strokes of CNS development in the
prenatal period. By contrast, during the postnatal period, micro-
glia play critical roles in CNS development, refinement, and
sculpting.
Because microglia are phagocytic, it has long been assumed
that their primary role in CNS development is to engulf and clear
the corpses of neurons that die as a result of programmed celldeath, which eliminates the excess of neurons that are gener-
ated as part of normal development (Marı´n-Teva et al., 2011).
However, microglia are not simply reactive waste collectors in
development, but rather, they are active neuronal killers, assas-
sinating neurons by inducing apoptosis. Several molecular
mechanisms by which microglia can directly instruct neuronal
apoptosis have been identified in different CNS regions
(Figure 2B): (1) by releasing superoxide ions in the cerebellum
(Marı´n-Teva et al., 2004), (2) through nerve growth factor in the
retina (Frade and Barde, 1998), or (3) through tumor necrosis fac-
tor a (TNFa) in the spinal cord (Sedel et al., 2004). In the hippo-
campus of neonatal mice, microglia-induced neuronal apoptosis
is dependent upon complement receptor 3 (CR3; comprised of
CD11b/CD18, integrin aM/integrin b2) (Wakselman et al., 2008)
and upon other cell surface receptors that transduce ‘‘kill-me’’
and ‘‘eat-me’’ signals (Schafer et al., 2013) expressed by neu-
rons that are committed to die. Activation of these microglial
cell surface receptors initiates intracellular downstream signaling
through KARAP/DAP12, ultimately triggering the release of theCell 158, July 3, 2014 ª2014 Elsevier Inc. 17
neurotoxic agents. The commitment of a particular neuron to die
may be made cell autonomously. Alternatively, the microglial
cells may also participate actively in the induction of kill-me
and eat-me signals in the neurons (Marı´n-Teva et al., 2011).
Numbers of neuronal precursors, as well as of differentiated neu-
rons, are regulated by microglia (Cunningham et al., 2013). Thus,
microglia regulate neuronal numbers in two important ways—
controlling neuronal precursors as well as neurons.
Perhaps not surprisingly, the involvement of microglia in con-
trolling neuron number is not as simple as being mediators of
programmed cell death. Paradoxically, eliminating microglia is
found to increase apoptosis of lamina V cortical neurons (Ueno
et al., 2013). These neurons were found to require trophic sup-
port from microglia-derived IGF1. Whether this developmental
role for microglia in maintaining rather than eliminating neurons
is specific for lamina V cortical neurons or applies to neuronal
subpopulations elsewhere in the CNS remains to be determined.
Synaptic Pruning in CNS Development
Not only does the developing CNS initially produce excessive
numbers of neurons, the neuronal axons typically make
exuberant synaptic connections to far more target neurons
than are maintained in the fully developed nervous system. The
projections are refined and sculpted to the mature architecture
as large numbers of synapses are eliminated. Synaptic elimina-
tion—‘‘synaptic pruning’’—has long been known to be depen-
dent on neuronal activity (Katz and Shatz, 1996), but over the
past decade, microglia have emerged as critical for this process
(Figure 2C). Indeed, in the cortex, the peak of microglial density
coincides with the peak of synaptogenesis (Bessis et al., 2007).
Developmental synaptic pruning has been extensively investi-
gated in the retinogeniculate system, where the initial wide-
spread and overlapping projections of retinal ganglion cells
(RGCs) from both eyes are progressively segregated into stereo-
typed eye-specific territories (Schafer et al., 2013). Pruning of
inappropriate RGC synapses in the lateral geniculate nucleus
(LGN) is achieved by microglial engulfment of the synapses,
both pre- and postsynaptic elements, in a retinotopically appro-
priate manner. The phagocytosis of the inappropriate synapses
is lost in mice lacking complement receptor 3 (CR3), which is
activated through the well-known classical complement
cascade that begins with C1q and proceeds to opsonization of
C3. In the CNS, CR3 is expressed only bymicroglia. Mice lacking
C1q, CR3, or C3 have sustained defects in eye-specific segrega-
tion (Schafer et al., 2012; Stevens et al., 2007), implicating
complement-dependent signaling as necessary for the synaptic
elimination. Microglial engulfment of RGC-LGN inputs coincides
with the period of postnatal development whenC1q is expressed
by RGCs. Using a retinal-specific deletion strategy (Bialas and
Stevens, 2013) demonstrated that expression of C1q by RGCs
depends upon their expression of TGFb receptor II (TGFbRII).
As eye-specific segregation and microglial engulfment of
RCG-LGN synapses is lacking in mice with retinal-specific loss
of TGFbRII, it appears that the requisite C1q comes from the
RGCs themselves rather than from microglia, which express
C1q continuously rather than phasically only during the period
of synaptic pruning. C1q is transiently expressed as well in the
developing neocortex and is necessary for proper elimination18 Cell 158, July 3, 2014 ª2014 Elsevier Inc.of exuberant synapses there (Chu et al., 2010). Thus, in the
context of the complement system in the CNS, the signal to
prune originates with the target neurons, but pruning is executed
by the microglia.
Microglial engulfment of synaptic elements has also been
observed in the developing hippocampus (Paolicelli et al.,
2011). In mice lacking the chemokine receptor CX3CR1, which
in the CNS is only expressed by microglia, the number of micro-
glia is transiently reduced in the developing hippocampus and
synaptic pruning is delayed. This deficient synaptic pruning
results in an excess of dendritic spines. Likewise, in the visual
cortex, synapses are regularly contacted bymicroglia processes
(Tremblay et al., 2010). A subset of synapses contacted by
microglia disappears, suggesting that microglia may promote
elimination of those in excess. Physiological synaptic pruning
by microglia during development appears to be a common pro-
cess for refining neuronal connectivity throughout the CNS. The
phagocytosis of synaptic elements by microglia is a nonphlogis-
tic process and, as such, is akin to phagocytosis by other tissue-
resident macrophages such as the removal of aged erythrocytes
by spleen red pulp macrophages (Davies et al., 2013) or engulf-
ment of bacteria by macrophages in lamina propria of the gut
(Danese, 2011). Therefore, developmental synaptic pruning by
microglia has commonalities with noninflammatory processes
of tissue-resident macrophages in homeostasis elsewhere in
the body.
Microglia Are Critical in Synaptic Maturation
In addition to synaptic pruning, microglia are required for proper
maturation of excitatory synaptic transmission. In CA1 hippo-
campal pyramidal neurons, the frequency and amplitude of mini-
ature excitatory postsynaptic currents (mEPSCs) are increased
in CX3CR1 null mice as compared with wild-type littermates
around postnatal day 13 (P13) (Paolicelli et al., 2011). Mice lack-
ing CX3CR1 show persistent alterations in excitatory transmis-
sion, but no differences have been found with inhibitory synaptic
transmission (Zhan et al., 2014). In addition, long-term depres-
sion (LTD) of excitatory synaptic transmission at developing
Schaffer collateral-CA1 synapses is markedly enhanced in
CX3CR1 null mice. The impairments caused by lack of CX3CR1
are suggestive of a role for microglia in maturation of synaptic
functioning (Figure 2C). Consistent with a role of microglia in syn-
aptic maturation, the functional properties of synapses develop
abnormally in P18-25 mice carrying a mutation in KARAP/
DAP12 (DAP12KI) (Roumier et al., 2004), a transmembrane
receptor encoded by TYROBP and expressed by microglia. In
the DAP12KI mice, glutamatergic synapses in the hippocampus
have decreased expression of AMPA receptors, in particular the
GluA2 subunit, compared with the wild-type. DAP12KI mice also
show increased synaptic GluN2B NMDA receptor function, indi-
cating loss of the normal developmental switch from GluN2B to
GluN2A. Synaptic plasticity is also aberrant in DAP12KI mice
with enhanced long-term potentiation (LTP), which may be
attributed to a relative increase in calcium-permeable AMPA re-
ceptors due to the suppressed synaptic expression of GluA2.
In the whisker-barrel region of the somatosensory cortex, the
‘‘barrel’’ cortex, microglia are recruited to the regions of thalamo-
cortical synapses, known as the barrel centers, around postnatal
Figure 3. Microglial-Derived BDNF Drives
Changes in Synaptic Formation Associated
with Learning and Memory
Motor task learning (indicated by the cartoon on
the right) is associated with changes in cortical
synaptic dynamics, as indicated by synaptic
maturation within the motor cortex (illustrated on
the left side of the figure). Microglial-released
BDNF (shown in blue being released from the
microglia in red) influences the formation of
synaptic structures in the motor cortex associated
with the successful learning of a motor task.
Genetic deletion of BDNF from CX3CR1-express-
ingmicroglia leads to a reduction in dendritic spine
dynamics and concomitant deficits in motor task
learning (see Parkhurst et al. [2013]).day 5. In CX3CR1 null mice, the invasion of microglial cells to the
barrel centers is delayed by several days, as is maturation of the
thalamocortical synapses (Hoshiko et al., 2012). At these
glutamatergic synapses, the ratio of the AMPA receptor-medi-
ated:NMDA receptor-mediated component of the ESPC in-
creases dramatically from P5 to P9. This increase is not
observed in CX3CR1 null mice. Over the same time period, there
is a developmental switch in the composition of the synaptic
NMDA receptor subunits, changing from predominantly GluN2B
containing to predominantly GluN2A containing. This develop-
ment switch appears absent or delayed in CX3CR1 null mice.
Thus, in both the hippocampus and barrel cortex and likely
broadly in the CNS, proper microglia function is required for
normal functional maturation of glutamatergic synapses.
Synaptic Plasticity and Learning in the Adult
What about synaptic functioning and plasticity in the normal
adult CNS? In a number of mutant mouse strains in which micro-
glia are lacking (e.g., CNS-TGFb-1 null mice) or in which micro-
glial signaling is disturbed (e.g., CX3CR1 nulls), basal synaptic
transmission and paired-pulse facilitation have been found to
be indistinguishable from those in the wild-type (Koeglsperger
et al., 2013; Rogers et al., 2011). Thus, although stimulating
microglia can affect synaptic transmission, as administering
LPS to stimulate microglia TLR4 receptors evokes increased fre-
quency of mEPSCs and EPSCs (Pascual et al., 2012), unstimu-
lated microglia in the healthy CNS have no demonstrable role
in ongoing, basal synaptic function. Rather, it is during the pro-
cesses of persistent synaptic plasticity when microglia come
into play.
Persistent synaptic plasticity can be broadly conceptualized
as either homeostatic—that which maintains synaptic function
in the proper range—or activity triggered— that which alters
synaptic efficacy, with the sign and magnitude of the alteration
exquisitely dependent upon the frequency and patterning of
synaptic inputs, postsynaptic neuronal firing, and synapse
type. Homeostatic plasticity is known to require glial-derived
TNFa (Stellwagen and Malenka, 2006). Though this cytokine
may be released from microglia (Kettenmann et al., 2013), the
specific role (if any) of microglia in homeostatic synaptic plas-
ticity remains to be determined.
Activity-triggered, persistent changes in synaptic efficacy are
commonly understood to be one of the fundamental cellular
mechanisms underlying learning and memory. Such persistent,activity-triggered synaptic plasticity may manifest as either an
increase or a decrease in synaptic efficacy, commonly referred
to as long-term potentiation (LTP) or long-term depression
(LTD). Learning and memory, particularly in the hippocampus,
is also highly dependent upon the proliferation and development
of new neurons—neurogenesis—which occurs in the healthy
adult as well as in the developing CNS (Frankland et al., 2013;
Shors et al., 2001). A recent spate of reports has put the spotlight
on microglia as critical regulators of activity-triggered synaptic
plasticity (Koeglsperger et al., 2013; Rogers et al., 2011; Schafer
et al., 2013), adult neurogenesis (Bachstetter et al., 2011;
Gemma and Bachstetter, 2013; Sierra et al., 2010), and
learning/memory (Parkhurst et al., 2013; Rogers et al., 2011;
Tremblay et al., 2011) (Figure 3). Microglia are also critical,
through CR3, in a newly discovered form of LTD that is activity
independent (Zhang et al., 2014).
The role of microglia in persistent, activity-triggered synaptic
plasticity in the adult has been investigated in mice engineered
to eliminate TGFb from the CNS (Butovsky et al., 2014; Koegl-
sperger et al., 2013). In such CNS-TGFb-1-deficient mice, the
number of microglia is dramatically reduced beginning from
E14.5, whereas neuron numbers are unaffected. The CNS-
TGFb-1-deficient animals are largely indistinguishable from
controls until about P90, after which the mutants lose weight,
exhibit dramatically reduced motor function, and die prema-
turely. Before observable changes have occurred, at 6–8 weeks
postnatally, activity-triggered persistent synaptic plasticity is
markedly altered in the hippocampus of the CNS-TGFb-1-
deficient mice. In these animals, LTP at Schaffer collateral-CA1
synapses is reduced, but conversely, LTD is enhanced. The pro-
found alterations in synaptic plasticity are dependent upon
enhanced activation of the GluN2B subtype of NMDA receptor
and are attributed to reduced recycling of glutamate. Although
it is possible that there are alterations in cells other than micro-
glia, the hippocampal synaptic plasticity deficits in CNS-
TGFb-1 nulls are consistent with those from mice lacking
CX3CR1, in which LTP is virtually eliminated (Rogers et al.,
2011). CX3CR1
/ mice were also shown to have profound
deficits in hippocampal-dependent learning and memory and
in hippocampal neurogenesis.
The CNS-TGFb-1-deficient mice lack CNS microglia from
early in development, and CX3CR1 is removed by a genomic
deletion in the CX3CR1 knockout mice. Thus, it is unclear as to
whether the changes in synaptic plasticity are secondary toCell 158, July 3, 2014 ª2014 Elsevier Inc. 19
developmental alterations or are due to alteration of synaptic
plasticity per se in the adult. Another important issue for
CX3CR1 nulls and other mouse mutants of genes expressed
commonly in the myeloid lineage (Figure 1) is that the primary
manipulation will be not only in microglia, but also in circulating
bone-marrow-derived macrophages. Both of these issues
were addressed elegantly by Parkhurst et al. (2013), who gener-
ated mice expressing tamoxifen-inducible Cre recombinase
under the control of the endogenous CX3CR1 promoter,
CX3CR1
CreER mice. A similar tamoxifen-inducible Cre recombi-
nase mouse was made by Yona et al., who focused on tissue-
resident macrophages outside of the CNS (Yona et al., 2013)
and microglia in CNS autoinflammation (Goldmann et al.,
2013). To restrict Cre-mediated recombination to microglia,
advantage was taken from the fact that microglia turn over at
a slow rate, whereas CX3CR1-expressing macrophages turn
over rapidly and are replenished from bone marrow precursors
that do not express CX3CR1 (Fogg et al., 2006). In mice with
CX3CR1
CreER, Cre-mediated recombination persisted in micro-
glia for more than a month after tamoxifen treatment, whereas
the recovery in the macrophage population started within days
of ending tamoxifen.
To probe necessary functions of microglia in the healthy adult
brain, Parkhurst et al. crossed CX3CR1
CreER mice with those
carrying the Rosa26-stop-DTR (R26iDTR) allele in which Cre-
mediated excision of a stop codon derepresses expression of
the diphtheria toxin receptor (DTR). Microglia, but not macro-
phages, were eliminated by treating CX3CR1
CreER: R26iDTR
mice first with tamoxifen and then 27 days later with diphtheria
toxin. Themicroglia-depletedmice showed deficits in contextual
fear conditioning and novel object recognition, tests of hippo-
campal-dependent learning, and in rotarod training, a test of
motor learning. Motor learning is associated with increased
spine dynamics in the motor cortex (Yang et al., 2009). By visu-
alizing spine dynamics over days in vivo, it was found that micro-
glia-depleted animals had reductions in both the elimination and
the formation of spines induced by the motor learning paradigm.
Importantly, the microglia elimination had no effect on brain
levels of inflammatory cytokines, nor were there any signs of
astrogliosis, problems that complicate the interpretation of other
studies (Butovsky et al., 2014; Rogers et al., 2011). Thus, the
findings by Parkhurst et al. are the strongest evidence to date
for the essential role of microglia in synaptic plasticity and
learning in the normal adult CNS.
In the coup de grace, an even more striking set of findings
revealed that a single microglial-expressed protein may be
responsible for most of the effects of microglia on synaptic plas-
ticity and learning (Parkhurst et al., 2013). This protein is brain-
derived neurotrophic factor (BDNF), a neurotrophin that is known
to regulate synaptic plasticity (Chen et al., 1999; Lessmann,
1998; Nakajima et al., 2002; Stoop and Poo, 1996) and to be
released by microglia (Trang et al., 2009). Treating CX3CR1
CreER
mice that were also homozygous for a floxed allele of BDNF with
tamoxifen persistently and selectively eliminated BDNF from
microglia. Mice in which BDNF was eliminated from microglia
showed deficits in contextual fear conditioning and motor
learning and in motor-learning-associated spine formation.
Thus, microglial-derived BDNF is necessary for normal learning20 Cell 158, July 3, 2014 ª2014 Elsevier Inc.and spine plasticity. Loss of BDNF recapitulates many aspects
of the synaptic plasticity and learning deficits caused by the
overall depletion of microglia. No changes were found in micro-
glia number, distribution, or proliferation or in the association of
microglia processes with spines, which might have accounted
for the deficits. Microglia-derived BDNF appears to act through
its cognate receptor TrkB to regulate the level of synaptic
GluN2B NMDA receptors. Eliminating BDNF expression by
microglia had no measurable effect on the total BDNF content
of the cortex or hippocampus, leading to the question as to
why the massive expression of BDNF from nonmicroglial cells
did not mask or compensate for the loss from microglia. BDNF
is observed in puncta in processes of microglia (Trang et al.,
2009), and as microglia processes may be preferentially drawn
to active synapses, perhaps BDNF is released very locally pre-
cisely where it is needed.
With the recent series of findings from many labs using many
approaches that demonstrate the uniqueness of microglia and
the necessity of microglia and microglia-specific signaling
processes in synaptic plasticity, learning, and neurogenesis,
there seems to be no turning away from the conclusion that
microglia are indispensable for the normal, physiological func-
tioning of the adult CNS. Many intriguing new questions have
arisen. If not BDNF, what accounts for the deficit in novel object
recognition? Is learning-associated synapse elimination depen-
dent on complement-mediated phagocytosis in the adult? Is
microglial-derived BDNF important in adult neurogenesis? If
not, what factor(s) is/are?
CNS Disorders when Noninflammatory Functions of
Microglia Go Awry
Those questions and no doubt many others will drive research to
expand our understanding of the breadth and depth of involve-
ment of microglia in the healthy CNS. Nevertheless, even from
the current understanding of microglia involvement, one may
hypothesize that aberrations in noninflammatory functions of
microglia, separate from their inflammatory functions, may
contribute to disease processes in the CNS.
Complement-Dependent Phagocytosis and Pruning in
Alzheimer’s Disease
The growing knowledge of the fundamental role of microglia in
synaptic elimination during development has important implica-
tions for understanding the mechanisms underlying synapse
elimination and dysfunction in the diseased CNS. Synapse loss
and dysfunction have emerged as early hallmarks of neuro-
degenerative diseases, suggesting that aberrant activation of
complement upregulation may reactivate the developmental
synapse elimination pathway to initiate synaptic loss. In partic-
ular, C1q associates with plaques in Alzheimer’s brains from in-
dividuals with Alzheimer’s disease (AD) (Afagh et al., 1996), and
in mouse models of AD, C1q deficiency has been shown to be
neuroprotective (Fonseca et al., 2004).
Recently, complement-dependent signaling has inde-
pendently come to the forefront of AD research using a
completely different type of approach to identify gene regulatory
networks for late-onset Alzheimer’s disease (LOAD) (Zhang
et al., 2013). This approach yielded an immune/microglia module
as the molecular system most strongly associated with the
pathophysiology of LOAD. Within this module, they identified a
major gene subnetwork tightly linked to complement. At the
center of this subnetwork is TYROBP, which encodes a trans-
membrane-signaling protein containing an immunoreceptor
tyrosine-based activation motif (ITAM). TYROBP is directly
coupled to ITGAM, the gene encoding CR3, and only two linkage
steps from C1q. Also, microglia-expressed TYROBP (KARAP/
DAP12) has been found to be directly involved in amyloid-b turn-
over and neuronal damage.
In other work, Griciuc et al. (2013) have found that human AD
brain tissue contains excess CD33, an immunoglobulin-like cell
surface protein, expressed in microglia. CD33 had been geneti-
cally linked to AD (Naj et al., 2011) and was linked to TYROBP in
Zhang et al. (2013). Griciuc et al. (2013) found that CD33 inhibited
uptake and clearance of Ab42 in microglial cell cultures and that
loss of CD33 reduces amyloid plaque burden in a severe mouse
model of AD, suggesting that dysregulation of CD33 plays a role
in disease pathogenesis. Thus, the constellation of recent dis-
coveries, including elucidation of the first gene network for
late-onset AD, is shifting the focus to the pathophysiological
roles of hijacking normal developmental processes in microglia.
Microglial Phagocytosis in Rett Syndrome
The critical role of microglial phagocytosis in the adult has been
brought into focus by work on mouse models of Rett syndrome,
an autism spectrum disorder caused by loss of the transcrip-
tional factor MeCP2 (Amir et al., 1999). Whereas selective loss
of MeCP2 in neurons recapitulates the full knockout phenotype,
the return of MeCP2 function in microglia surprisingly rescued
major phenotypic abnormalities caused by lack of MeCP2 (Der-
ecki et al., 2012). MeCP2-deficient mice in which microglia
MeCP2 function was reconstituted either by wild-type bone
marrow transplant following irradiation or by microglia expres-
sion driven by Lysm-cre showed a dramatic improvement in life-
span, breathing patterns, and locomotor activity compared with
mice transplanted with bone marrow from MeCP2-deficient
mice. Phagocytosis was implicated as critical in the rescue
because infusion of annexin V, which prevents recognition of
debris by phagocytes, prevents the beneficial effects of restoring
MeCP2.
Hoxb8+ Microglia: Link to a Compulsive Disorder
Hierarchical clustering analysis, which so dramatically demon-
strates the differences between microglia and macrophages
(Butovsky et al., 2014), has suggested that there may be micro-
glial subpopulations with distinct transcriptomes. This concept
builds on numerous studies showing functional, morphological
subpopulations of microglia in different CNS regions (Scheffel
et al., 2012; Vinnakota et al., 2013). One transcriptionally unique
subpopulation of interest is that expressing the transcriptional
factor Hoxb8. Hoxb8-expressing cells represent about 15% of
the CD11b+ population in the adult CNS and may be ontogeni-
cally distinct from the yolk-sac-derived dominant population of
microglia (S. De et al., 2013, Soc. Neurosci., abstract). Mice
with complete loss of Hoxb8 or specific deletion in Tie2-express-
ing cells (myeloid and endothelial cells) show excessive groom-
ing, leading to hair loss and skin lesions (Chen et al., 2010). The
behavioral alterations are rescued by transplanting bonemarrow
from mice expressing Hoxb8 following irradiation, suggesting
that reconstitution of Hoxb8+ myeloid is needed for normalgrooming behavior. The excessive grooming behavior in mice
is reminiscent of the human obsessive-compulsive disorder
trichotillomania, raising the possibility that defects in the normal
function of Hoxb8 in microglia may play a role in this disorder.
Microglia BDNF Signaling in Neuropathic Pain
Altered neuron-microglia-neuron signaling is increasingly recog-
nized as being a core dysfunction in pain hypersensitivity after
injury to peripheral nerves (Beggs et al., 2012; Tsuda et al.,
2003, 2013). A major node in the core signaling network for
nerve-injury-induced pain hypersensitivity is the release of
BDNF from microglia in the spinal cord (Coull et al., 2005), the
effects of which are mediated through TrkB receptors, leading
to disinhibition of pain-transmitting neurons in the dorsal horn.
Generalizing from the findings of Parkhurst et al. (2013), the
pain hypersensitivity process may be an exaggeration of the
physiological action of microglia-derived BDNF in learning and
plasticity but in the context of a different neuronal network. In
the motor cortex, microglia-derived BDNF is needed to facilitate
the output of the motor programing network, resulting in
enhanced motor performance. When microglia-derived BDNF
facilitates the output of the dorsal horn pain-transmitting
network, the result is enhanced pain.
Many aspects of the signaling pathways upstream and down-
stream from BDNF in microglia have been worked out in the
context of nerve-injury-induced pain (Beggs et al., 2012). Down-
stream, after being released from microglia, BDNF activates
neuronal TrkB receptors, leading to downregulation of the potas-
sium-chloride cotransporter KCC2, with resultant accumulation
of intracellular Cl in the neurons and suppressed inhibition
(Coull et al., 2003). Whether lessening of Cl-mediated inhibition
participates in the physiological plasticity and learning that
depend upon microglia-derived BDNF in the adult is unknown.
During development, intracellular Cl is elevated, and KCC2
expression is low, contributing to heightened synaptic plasticity
(Rivera et al., 1999); thus, it is possible that microglia-derived
BDNF could play a role here. The dominant upstream pathway
for microglial BDNF in the context of pain hypersensitivity is
activation of P2X4 receptors, which causes increased intra-
cellular Ca2+ and activation of p38 MAP kinase. This signaling
pathway drives transcription, translation, and release per se of
BDNF from microglia (Trang et al., 2009). Expression of P2X4
receptors by the microglia is, in turn, driven by convergence of
a number of signaling cascades involving integrin and chemo-
kine receptors that are initiated following nerve injury (Biber
et al., 2011; Masuda et al., 2012; Toyomitsu et al., 2012; Tsuda
et al., 2009a, 2009b). Importantly, the site of injury in the periph-
eral nerve is far removed from the microglia response in the spi-
nal cord, and hence this is not an inflammatory response to local
injury.
The P2X4 receptor-BDNF-TrkB-KCC2 pathway expression is
not only critical for pain hypersensitivity after peripheral nerve
injury, but also for the paradoxical hyperalgesic effect of
morphine and other opioids (Ferrini et al., 2013). Thus, exagger-
ation of the physiological plasticity induced by microglia-derived
BDNFmay have a number of pathological sequelae. Conversely,
suppression of BDNF frommicroglia may contribute to disorders
in which there is reduced plasticity, such as schizophrenia
(Buckley et al., 2011) or AD (Nistico` et al., 2012).Cell 158, July 3, 2014 ª2014 Elsevier Inc. 21
Concluding Remarks
The recent flood of evidence demonstrates that microglia are a
specialized cell population that have multiple roles in shaping
and refining neuronal connectivity during development and in
activity-dependent synaptic plasticity, neurogenesis, and
learning in the fully mature CNS. Microglia can detect, process,
and respond to signals in an entirely noninflammatory way.
The duality of microglia with noninflammatory as well as in-
flammatory functions provides a challenge to the concept that
all disorders involving microglia are de facto neuroinflammatory
disorders. Rather, some CNS disorders, or endophenotypes of
disorders, may better be conceptualized as resulting from loss
or gain of noninflammatory microglia functions. We anticipate
that advancing understanding of these functions of microglia
will not only deepen knowledge of fundamental CNS mecha-
nisms, but will also reveal new strategies for diagnosing and
treating CNS disorders.ACKNOWLEDGMENTS
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